Literature DB >> 15242741

Cellular and molecular mechanisms of systolic and diastolic dysfunction in an avian model of dilated cardiomyopathy.

Yiming Wu1, Anthony H Tobias, Kenneth Bell, William Barry, Michiel Helmes, Karoly Trombitas, Russell Tucker, Kenneth B Campbell, Henk L Granzier.   

Abstract

We investigated the cellular and molecular mechanisms of systolic and diastolic dysfunction in a furazolidone (Fz)-induced model of dilated cardiomyopathy (DCM) in turkey poults. Serial echocardiograms disclosed marked systolic dysfunction in the Fz-treated poults, and ventricular weight and left ventricular (LV)/body weight ratio were significantly increased. Isolated heart experiments were performed to determine LV pressure-volume (P-V) relationships. In addition, LV sarcomere lengths (SLs) were measured after hearts had been fixed, and wall stress (sigma)-SL relationships were determined. When compared to control hearts, LV chamber volume in DCM hearts was approximately 3-fold increased, the active or developed LV P-V relationship was markedly depressed, the passive or diastolic P-V relationship was steeper, and SLs were significantly shorter. However, the developed sigma-SL relationships of DCM and control hearts were not different indicating that intrinsic myocardial capacity to generate active force is unaffected in this model of DCM. In contrast, passive sigma, and passive tension in trabecular muscle preparations increased much more steeply with SL in DCM than normal hearts. Trabecular muscle experiments disclosed that the increase in passive myocardial stiffness was primarily collagen based. Titin, the giant sarcomeric molecule, which is an important determinant of passive myocyte properties in normal myocardium, did not contribute significantly to increased passive myocardial stiffness in DCM. We conclude that increased collagen-based passive myocardial stiffness is the major cause of the steeper passive or diastolic P-V relationship in DCM. Further, altered passive myocardial properties and ventricular geometry in DCM play a critical role to reduce ventricular systolic function by limiting SL extension during diastole, thereby limiting the use of the myocardial length-tension relationship.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15242741     DOI: 10.1016/j.yjmcc.2004.04.010

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  10 in total

Review 1.  Fibrosis in heart disease: understanding the role of transforming growth factor-beta in cardiomyopathy, valvular disease and arrhythmia.

Authors:  Razi Khan; Richard Sheppard
Journal:  Immunology       Date:  2006-05       Impact factor: 7.397

2.  Passive mechanical properties of cardiac tissues in heart hypertrophy during pregnancy.

Authors:  Adolfo Virgen-Ortiz; J L Marin; A Elizalde; E Castro; E Stefani; L Toro; J Muñiz
Journal:  J Physiol Sci       Date:  2009-06-30       Impact factor: 2.781

3.  Increased myocardial stiffness due to cardiac titin isoform switching in a mouse model of volume overload limits eccentric remodeling.

Authors:  Kirk R Hutchinson; Chandra Saripalli; Charles S Chung; Henk Granzier
Journal:  J Mol Cell Cardiol       Date:  2014-11-08       Impact factor: 5.000

4.  Static and dynamic properties of the HCM myocardium.

Authors:  Shannamar Dewey; Qian Xu; Aldrin Gomes
Journal:  J Mol Cell Cardiol       Date:  2010-08-10       Impact factor: 5.000

5.  Extensible behavior of titin in the miniswine left ventricle.

Authors:  Martin M Lewinter; Joseph Popper; Mark McNabb; Lori Nyland; Stephen B Bell; Henk Granzier
Journal:  Circulation       Date:  2010-02-01       Impact factor: 29.690

6.  CaMKII effects on inotropic but not lusitropic force frequency responses require phospholamban.

Authors:  Yiming Wu; Elizabeth D Luczak; Eun-Jeong Lee; Carlos Hidalgo; Jinying Yang; Zhan Gao; Jingdong Li; Xander H T Wehrens; Henk Granzier; Mark E Anderson
Journal:  J Mol Cell Cardiol       Date:  2012-07-11       Impact factor: 5.000

7.  Upregulation of lysyl oxidase and MMPs during cardiac remodeling in human dilated cardiomyopathy.

Authors:  P Sivakumar; Sudhiranjan Gupta; Sagartirtha Sarkar; Subha Sen
Journal:  Mol Cell Biochem       Date:  2007-09-12       Impact factor: 3.396

8.  Atorvastatin therapy during the peri-infarct period attenuates left ventricular dysfunction and remodeling after myocardial infarction.

Authors:  Xian-Liang Tang; Santosh K Sanganalmath; Hiroshi Sato; Qiuli Bi; Greg Hunt; Robert J Vincent; Yong Peng; Gregg Shirk; Buddhadeb Dawn; Roberto Bolli
Journal:  PLoS One       Date:  2011-09-28       Impact factor: 3.240

Review 9.  Avian cardiomyocyte architecture and what it reveals about the evolution of the vertebrate heart.

Authors:  Holly A Shiels
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2022-10-03       Impact factor: 6.671

10.  Calreticulin-STAT3 signaling pathway modulates mitochondrial function in a rat model of furazolidone-induced dilated cardiomyopathy.

Authors:  Ming Zhang; Jin Wei; Hu Shan; Hao Wang; Yanhe Zhu; Jiahong Xue; Lin Lin; Rui Yan
Journal:  PLoS One       Date:  2013-06-20       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.